Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Collagen biology and non‐invasive biomarkers of liver fibrosis
M.A. Karsdal, Samuel J. Daniels, Signe Holm Nielsen, et al.
Liver International (2020) Vol. 40, Iss. 4, pp. 736-750
Open Access | Times Cited: 160

Showing 26-50 of 160 citing articles:

Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis
Diana Julie Leeming, Federica Genovese, Jannie Marie Bülow Sand, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Anne Linde Mak, Jenny Lee, Anne‐Marieke van Dijk, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1920-1920
Open Access | Times Cited: 32
Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis
Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Peder Frederiksen, et al.
JHEP Reports (2021) Vol. 3, Iss. 4, pp. 100317-100317
Open Access | Times Cited: 30
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development
Tongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, et al.
Gastroenterology (2021) Vol. 162, Iss. 4, pp. 1210-1225
Open Access | Times Cited: 29
Clinical importance of laboratory biomarkers in liver fibrosis
Valdas Banys, Goda Aleknavičiūtė-Valienė
Biochemia Medica (2022) Vol. 32, Iss. 3, pp. 346-356
Open Access | Times Cited: 20
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
Luca Valenti, Armando Tripodi, Vincenzo La Mura, et al.
JHEP Reports (2022) Vol. 4, Iss. 12, pp. 100598-100598
Open Access | Times Cited: 20
Chemotherapy treatment induces pro-invasive changes in liver ECM composition
Justinne R. Guarin, Jackson P. Fatherree, Madeleine J. Oudin
Matrix Biology (2022) Vol. 112, pp. 20-38
Open Access | Times Cited: 19
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
Pratima Nangia‐Makker, Victor Hogan, Vitaly Balan, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102622-102622
Open Access | Times Cited: 19
Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single‐blind, placebo‐controlled study in F2/F3 NASH
Stephen A. Harrison, Patrick Mayo, Todd M. Hobbs, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3379-3392
Open Access | Times Cited: 19
A Unification of Nanotopography and Extracellular Matrix in Electrospun Scaffolds for Bioengineered Hepatic Models
Yunxi Gao, Thomas S. R. Bate, Anthony Callanan
ACS Applied Bio Materials (2023) Vol. 6, Iss. 6, pp. 2158-2171
Open Access | Times Cited: 11
Metabolic dysfunction−associated liver disease and diabetes: Matrix remodeling, fibrosis, and therapeutic implications
Weiguo Fan, Toby M. Bradford, Natalie J. Török
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 21-33
Closed Access | Times Cited: 4
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 798-798
Open Access | Times Cited: 4
From Monocyclization to Pentacyclization: A Versatile Plant Cyclase Produces Diverse Sesterterpenes with Anti‐Liver Fibrosis Potential
Kai Guo, Xue Tang, Yanchun Liu, et al.
Advanced Science (2025)
Open Access
Association between mixed exposure of non-persistent pesticides and liver fibrosis in the general US population: NHANES 2013–2016
Shuge Shu, Yuan Li, Xiangyu Yu, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 290, pp. 117776-117776
Open Access
Circulating collagen type I fragments as specific biomarkers of cardiovascular outcome risk: Where are the opportunities?
Emily Medlin Martin, Joan Chang, Arantxa González, et al.
Matrix Biology (2025) Vol. 137, pp. 19-32
Open Access
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
M.A. Karsdal, Thomas R. Cox, Amelia L. Parker, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1856-1856
Open Access
LKB1 activated by NaB inhibits the IL-4/STAT6 axis and ameliorates renal fibrosis through the suppression of M2 macrophage polarization
Weifei Liang, Heming Wu, Qishan Long, et al.
Life Sciences (2025), pp. 123564-123564
Closed Access
Skullcapflavone II induces G2/M phase arrest in hepatic stellate cells and suppresses hepatic fibrosis
Guoyi Rong, Jun Liu, Yi Yang, et al.
European Journal of Pharmacology (2025), pp. 177522-177522
Open Access
Evaluating the Effectiveness of Pegbelfermin in MASH‐Associated Hepatic Fibrosis A Meta‐Analysis and Systematic Review of Randomized Controlled Trials
Muhammad Shahzil, Fariha Hasan, Syeda Kanza Kazmi, et al.
JGH Open (2025) Vol. 9, Iss. 3
Open Access
Signaling networks in cancer stromal senescent cells establish malignant microenvironment
Yue Zhang, Teh-Wei Wang, Maho Tamatani, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 14
Open Access
Maternal Protein Restriction Compromises Hepatic Phenotype and Antioxidant Defense in Postweaning Male Rats, While Females Exhibit Resilience.
André Matheus Leandro Franzolin, Matheus Naia Fioretto, Isabelle Tenori Ribeiro, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 766, pp. 151873-151873
Closed Access
A Comparative Study of N-Acetyl Cysteine, Rosuvastatin, and Vitamin E in the Management of Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Trial
Amr Y. Zakaria, Rehab Badawi, Hasnaa Osama, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 650-650
Open Access
Matrix stiffness and shear stresses modulate hepatocyte functions in a fibrotic liver sinusoidal model
Wang Li, Peiwen Li, Ning Li, et al.
AJP Gastrointestinal and Liver Physiology (2020) Vol. 320, Iss. 3, pp. G272-G282
Open Access | Times Cited: 32
Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases
M.A. Karsdal, Virginia B. Kraus, Diane E. Shevell, et al.
Autoimmunity Reviews (2020) Vol. 20, Iss. 1, pp. 102706-102706
Closed Access | Times Cited: 30
An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution
Martin Pehrsson, Tina Manon‐Jensen, Shu Sun, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1605-1617
Open Access | Times Cited: 17

Scroll to top